期刊文献+

趋化因子Fractalkine在骨癌痛大鼠中的作用及其脊髓机制 被引量:3

The Role of Fractalkine in Pain Facilitation and Spinal Mechanism in Rat Model of Bone Cancer Pain
原文传递
导出
摘要 目的探讨趋化因子Fractalkine在骨癌痛中的作用及其脊髓部位的作用机制。方法采用Walker 256肿瘤细胞,注射在胫骨内建立骨癌痛模型。雌性SD大鼠40只,随机分为5组(n=8),Ⅰ组为Hank’s液对照组,Ⅱ组为骨癌痛组,Ⅲ组为对照组+CX3CR1中和抗体,Ⅳ组为骨癌痛组+IgG;Ⅴ组为骨癌痛组+CX3CR1中和抗体。术后第10~12天,鞘内分别注射CX3CR1中和抗体或IgG,每天1次,剂量10μg/10μl。分别于术前及术后隔日开始测定大鼠机械性痛阈值。术后第12天鞘内注射抗体后6 h处死大鼠,测定脊髓小胶质细胞标志物(OX-42)的表达水平。结果术后第10~12天,与Ⅰ组比较,Ⅱ组、Ⅳ组机械性痛阈值显著下降,脊髓OX-42染色阳性细胞数(Num)及积分吸光度(IA)显著增加,差异均有高度统计学意义(均P<0.01),Ⅲ组上述指标的差异无统计学意义(P>0.05);与Ⅱ组、Ⅳ组比较,Ⅴ组机械性痛阈值显著增高,脊髓OX-42染色Num及IA显著减少,差异均有高度统计学意义(均P<0.01)。结论Fractalkine通过激活脊髓小胶质细胞参与了骨癌痛的形成。 Objective To investigate the role of Fractalkine in pain facilitation and spinal mecha-nisms in the rat model of bone cancer pain.Methods The bone cancer pain model was developed by inoculated Walker 256 mammary gland carcinoma cells into the tibia medullary cavity.Fouty SD female rats were divided into 5 groups(n=8 each) randomly : groupⅠ: sham operation;groupⅡ:model group;group Ⅲ: control group+anti-CX3CR intrathecal(IT);group Ⅳ: model group+ normal IgG IT,groupⅤ: model group+anti-CX3CR1 IT.Anti-CX3CR1 or normal IgG was injected IT during 10 to 12th day.Von Frey threshold was measured one day before operation and every 2 days after operation.On the 12th day after operation,rats were sacrificed after IT injection of either anti-CX3CR1 or normal IgG,the lumbar 4-6 spinal cord was removed.The expression of the spinal OX-42(microglial marker) was detected by immunohistochemistry assay.Results From the 10 to 12th day after operation,von Frey threshold in groupsⅡand Ⅳ was significantly lower than that in group I and group Ⅲ(P〈0.01),groupⅤwas remarkly higher than that in group Ⅳ(P〈0.01).The spinal OX-42 expression in group Ⅱor Ⅳ was significantly increased compared with that in groupⅠor Ⅲ(P〈0.01),IT anti-CX3CR1 was significantly suppressed OX-42 expression(P〈0.01).Conclusion Fractalkine is involved in the bone cancer pain via activation of spinal microglia.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2008年第6期897-899,922,I0009,共5页 Suzhou University Journal of Medical Science
基金 江苏省自然科学研究基金资助项目(2005033) 江苏省卫生厅基金资助项目(K200518)
关键词 骨癌痛 痛觉过敏 胶质细胞 FRACTALKINE 脊髓 bone cancer pain hyperalgesic glia cell Fractalkine spinal
  • 相关文献

参考文献13

  • 1Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for pathological pain [J]. Trends Neurosci 2001, 24(8):450-455.
  • 2McMahon SB, Cafferty WB, Marchand F. Immune and glial cell factors as pain mediators and modulators[J]. Exp Neurol, 2005, 192(2):444-462.
  • 3Verge GM, Milligan ED, Maier SF, et al. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia (DRG) under basal versus neuropathic pain conditions[J]. Eur J Neurosci, 2004,20(5): 1150-1160.
  • 4Miltigan ED, Zapata V, ChacurM, etal. Evidence that exogenous and endogenous fractalkine can induce spinal no- ciceptivefacilitation in rats [J]. Eur J Neurosci, 2004, 20 (9):2294-2302.
  • 5杨建平,蒋豪.大鼠蛛网膜下腔埋管并长期留置操作的改进[J].中华麻醉学杂志,1993,13(2):110-112. 被引量:123
  • 6姚明,杨建平,王丽娜,成浩,张艳兵,许期年,吴翼伟.腹水传代与体外培养Walker 256癌细胞系建立大鼠骨癌痛模型的可行性[J].中华医学杂志,2008,88(13):880-884. 被引量:61
  • 7Hughes PM, Batham MS, Frentzel S, et ol. Expression of fractalkine (CX3CL1) and its receptor (CX3CR1), during acute and chronic inflammation in the rodent CNS[J]. Glia, 2002,37(4):314-327.
  • 8Jung S, Aliberti J, Graemmel P, et al. Analysis of fractalkine receptor CX3CR1 function by targeted deletionand green fluorescent protein reporter gene insertion [J]. Mol Cell Biol, 2000,20(11): 4106-4114.
  • 9Chapman GA, Moores K, Harrison D, et al. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage[J]. J Neurosci, 2000,20:87.
  • 10Zhang RX, Liu B, Wang L, et al. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia[J]. Pain, 2005, 118(1-2): 125-136.

二级参考文献13

  • 1Rubens RD. Bone metastases-the clinical problem. Eur J Cancer, 1998, 34: 211-213.
  • 2Medhursta SJ, Walker K, Bowes M, et al. A rat model of bone cancer pain, Pain, 2002, 96:129-140.
  • 3Zhang RX, Liu B, Wang L, et al. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain, 2005, 118 : 125-136.
  • 4Schwei MJ, Honore P, Rogers SD, et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci ,1999, 19: 10886-10897.
  • 5Halvorson KG, Kubota K, Sevcik MA, et al. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res, 2005, 65 : 9426-9435.
  • 6Walker K. Fox AJ, Urban LA. Animal models for pain research. Mol Med Today, 1999, 5: 319-321.
  • 7Corbello Pereira SR, Darronqui E, Constantin J, et al. The urea cycle and related pathways in the liver of Walker-256 tumorbearing rats. Biochim Biophys Acta, 2004, 1688: 187-196.
  • 8Yao YM, Liu QG, Yang W, et al. Effect of spleen on immune function of rats with liver cancer complicated by liver cirrhosis. Hepatobiliary Pancreat Dis Int, 2003, 2: 242-246.
  • 9Chew EC, Wallace AC. Demonstration of fibrin in early stages of experimental metastases. Cancer Res, 1976, 36:1904-1909.
  • 10Menendez L, Lastra A, Fresno MF et al. Initial thermal heat hypoalgesia and delayed hyperalgesia in a routine model of bone cancer pain. Brain Res, 2003, 969: 102-109.

共引文献163

同被引文献44

  • 1宋雪松,徐艳冰,曹君利,何建华,张励才,曾因明.cAMP反应元件结合蛋白介导磷酸化细胞外信号调节激酶在神经病理性痛形成中的作用[J].生理学报,2005,57(2):139-146. 被引量:16
  • 2Dai Y, Wang H , Ogawa A, et al. Ca^2+/calmodulin-dependent protein kinase Ⅱ in the spinal cord contributes to neuropathic pain in a rat model of mononeuropathy [ J]. Eur J Neurosei, 2005,21 ( 9 ) : 2467 - 2474.
  • 3Bruggemann I, Schulz S, Wibomy D, et al. Colocalization of the π-opioid receptor and Calcium/calmodulin-dependent kinase Ⅱ in distinct pain-processing brain regions[ J ]. Brain Res Mol Brain Res,2000,85(1/2) : 239 -250.
  • 4Fang L, Wu J, Lin Q, et al. Calcium-calmodulin-dependent protein kinase Ⅱ contributes to spinal cord central sensitization[ J]. J Neurosci ,2002,22(10) :4196 -4204.
  • 5Galana A, Laird JM, Cervero F, et al. In vivo recruitment by painful stimuli of AMPA receptor subunits to the plasma membrane of spinal cord neurons [ J ]. Pain, 2004, 112 (3) :315 -323.
  • 6Toni LJ, Adam CL, Linda SS. Secondary hyperalgesia in the postoperative pain Model is dependent on spinal calcium/ealmodulin dependent protein kinase Ⅱα activation[J].Anesth Analg ,2007, 105 (6) : 1650 - 6.
  • 7Takako M, Vjekoslav M. Multiple kinase pathways mediate the early sciatic ligation-associated activation of CREB in the rat spinal dorsal horn [J]. Neurosci Lett, 2005,381 (1/2) : 80 -85.
  • 8Seong SC, Young JS, Eon JS, et al. Involvement of phosphorylated Ca^2+/calmodulin-dependent protein kinase Ⅱ and phosphorylated extracellular signal-regulated protein in the mouse formalin pain model[ J ]. Brain Res, 2006,1108 (1): 28-38.
  • 9Chen GD, Peng ML, Wang PY, et al. Calcium/calmodulin-dependent kinase Ⅱ mediates NO-elicited PKG activation to participate in spinal reflex potentiation in anesthetized rats [ J ]. Am J Physiol Regul Integr Comp Physiol, 2008,294(2) : 487 -493.
  • 10Schwei MJ, Honore P, Rogers SD, et al. Neuro- chemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci, 1999, 19 : 10886- 10897.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部